Aprogen Medicines Inc. (KRX:007460)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,500.00
+190.00 (8.23%)
Aug 3, 2026, 3:30 PM KST

Aprogen Medicines Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
34,54145,14837,16235,68443,07015,894
Short-Term Investments
-----4,000
Trading Asset Securities
5,9215,6126,5005,0004,390-
Cash & Short-Term Investments
40,46250,76043,66240,68447,46019,894
Cash Growth
-7.25%16.26%7.32%-14.28%138.57%-91.62%
Accounts Receivable
27,08325,97619,67424,80921,3891,567
Other Receivables
3,9903,5581,1701,6077,9889,759
Receivables
52,62360,61224,35634,63792,30656,990
Inventory
65,60460,89462,48360,81561,46723,257
Prepaid Expenses
2,2861,179967.42847.35913.48906.58
Other Current Assets
5,5415,1992,8497,2249,4322,052
Total Current Assets
166,517178,643134,317144,207211,578103,099
Property, Plant & Equipment
361,905367,267364,181362,959365,100314,479
Long-Term Investments
12,71719,2969,7902,4473,29854,786
Goodwill
50,95850,958----
Other Intangible Assets
17,38617,4156,1067,4898,4312,633
Long-Term Deferred Tax Assets
2,8372,683--662.84-
Long-Term Deferred Charges
55,20254,42046,60134,6254,988-
Other Long-Term Assets
22,05422,7883,9021,2245,2221,904
Total Assets
696,518717,265609,968594,428599,853477,646

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
12,6825,0143,4232,7344,1863,920
Accrued Expenses
5,2324,4452,6832,5564,1178,410
Short-Term Debt
100,579101,11435,78446,63149,763398,613
Current Portion of Long-Term Debt
47,00045,00045,00044,9387,675-
Current Portion of Leases
863.251,030592.23560.08934.882,785
Current Income Taxes Payable
--246.72-4.18-
Current Unearned Revenue
696.15234.25----
Other Current Liabilities
29,45426,93225,23128,22223,2538,202
Total Current Liabilities
196,506183,769112,959125,64089,933421,929
Long-Term Debt
38,00040,00032,00032,00031,25131,046
Long-Term Leases
652.43718.46326.69288.35571.0319,925
Pension & Post-Retirement Benefits
15,98016,83515,69411,74010,3194,076
Long-Term Deferred Tax Liabilities
8,7178,7346,5905,3755,3221,167
Other Long-Term Liabilities
5,8448,5982,3081,6961,455309.39
Total Liabilities
265,699258,655169,878176,740138,851478,453

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
164,653164,653152,062132,419126,834260,351
Additional Paid-In Capital
521,804521,069512,886472,949431,64146,794
Retained Earnings
-510,220-488,200-418,506-358,604-293,691-192,837
Treasury Stock
-98,115-98,115-98,115-98,115-98,084-
Comprehensive Income & Other
62,47458,90410,306-849.6748,392-112,146
Total Common Equity
140,596158,310158,634147,800215,0922,163
Minority Interest
290,223300,300281,457269,888245,910-2,970
Shareholders' Equity
430,819458,610440,091417,688461,002-806.44
Total Liabilities & Equity
696,518717,265609,968594,428599,853477,646

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
187,095187,862113,702124,41790,195452,369
Net Cash (Debt)
-146,633-137,102-70,041-83,732-42,736-432,475
Net Cash Growth
------
Net Cash Per Share
-7276.63-6913.76-4062.06-5318.10-3167.42-37416.92
Filing Date Shares Outstanding
20.5720.5718.8916.2715.534.43
Total Common Shares Outstanding
20.5720.5718.8916.2715.534.43
Working Capital
-29,989-5,12621,35718,567121,644-318,829
Book Value Per Share
6835.107696.278397.299083.1113851.34488.78
Tangible Book Value
72,25389,938152,528140,311206,661-469.92
Tangible Book Value Per Share
3512.584372.338074.108622.8813308.41-106.18
Land
60,08160,08150,01244,13644,19012,484
Buildings
122,711122,711115,772115,622113,61188,041
Machinery
268,416268,124221,978195,122191,265137,051
Construction In Progress
29,13929,56661,140107,58088,23485,017